Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy.
Jiang T, Yang Z, Su Q, Fang L, Xiang Q, Tian C, Gao Q, Mao C, Huang CZ, Zuo H.
Jiang T, et al. Among authors: yang z.
ACS Appl Mater Interfaces. 2025 Jan 22. doi: 10.1021/acsami.4c18550. Online ahead of print.
ACS Appl Mater Interfaces. 2025.
PMID: 39841045